Could a diabetes drug help heart failure patients shed excess fluid?
NCT ID NCT05553938
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study investigates whether empagliflozin, a drug typically used for diabetes, can help people with worsening heart failure get rid of extra fluid. Researchers will give 60 participants either empagliflozin or a placebo for six weeks, alongside their usual diuretic medication, and measure how much salt and water their kidneys remove. The goal is to see if empagliflozin improves fluid balance, which could ease symptoms like swelling and shortness of breath.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
empagliflozin
What this could lead to
If successful, this could show that empagliflozin helps heart failure patients get rid of excess fluid more effectively, potentially reducing hospital visits.
What could go wrong
This is an early-phase study with only 60 participants, so results may not apply to all heart failure patients. The drug may not improve fluid removal or could cause side effects like dehydration or kidney issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart Nerve Imaging Trial with 18F-mFBG (NCT04535193)
- HARMONY-HF: Remote Monitoring for Heart Failure NCT07680634
- ARTORIA-R: ACHD Transplant Waiting List Study (NCT04848844)
- DCD vs DBD Heart Transplant Safety Study (NCT05462041)
- CESAR Study: Heart Evaluation Cohort (NCT07675434)
- Early Heart Failure Detection Tool Study (NCT07673562)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
-
Yale University
New Haven, Connecticut, 06520, United States